JAK1 and hepatocellular carcinoma: The previous in vitro study suggested that PIVKA‐II acts as an autologous mitogen in three different HCC cell lines, which induces cell proliferation through the Janus kinase 1‐ Signal transducer and activator of transcription 3 (JAK1‐STAT3) signaling pathway.35